Tuberculosis Modelling
Today I had the pleasure of speaking to Hojoon Sohn, an associate professor in infectious disease epidemiologist at the Seoul National University College of Medicine. Hojoon is an expert in TB modelli...
28 Helmi 202330min
Therapeutic Drug Monitoring in TB
Today we speak to Professor Jan-Willem Alffenaar from Westmead Hospital and the University of Sydney about Therapeutic Drug Monitoring in Tuberculosis. Professor Alffenaar reviews the PK/PD issues wit...
31 Tammi 202333min
Predicting Side Effects in 3HP
Today we speak with Professor Jann-Yuan Wang, a clinician and researcher in Taiwan, about his work in latent tuberculosis. Professor Wang speaks about his experience using 3HP and the challenges of sy...
1 Tammi 202318min
Treatment of Drug Resistant TB
Drug Resistant TB is a growing problem with some exciting advances over the past decade. With the recent Rapid Communication from the WHO and the advent of the B-PALMS regimen, drug resistant TB is a ...
1 Joulu 202234min
Vaccination in Tuberculosis
BCG has long been the only widely used vaccination strategy since it's initial use over 100 years ago. In high TB burden settings it is still recommended in children to protect against disseminated di...
7 Marras 202224min
Ethical Issues in Tuberculosis
How does stigma impact treatment in tuberculosis? Has the COVID-19 pandemic enabled high income countries to commiserate with lower middle income countries who have high infectious disease burden? Are...
18 Touko 202238min
Child and Adolescent Tuberculosis
Tuberculosis is a global health priority and a major cause of child and adolescent morbidity and mortality. Approximately 1.5 million children and adolescents are infected with tuberculosis each year...
24 Maalis 202228min
The TB Practecal Study
Philipp is the co-head of the Burnet Institute Tuberculosis Elimination and Implementation Science Group. He is an infectious diseases specialist with more than 15 years of extensive clinical and publ...
13 Joulu 202126min
